{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:32:50Z","timestamp":1775856770294,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L212001"],"award-info":[{"award-number":["L212001"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2102900"],"award-info":[{"award-number":["2021YFC2102900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2101503"],"award-info":[{"award-number":["2021YFC2101503"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131629","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T03:00:20Z","timestamp":1713236420000},"page":"131629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["Unraveling the mechanisms of Sofosbuvir resistance in HCV NS3\/4A protease: Structural and molecular simulation-based insights"],"prefix":"10.1016","volume":"267","author":[{"given":"Muhammad","family":"Shahab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131629_bb0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"Alter","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131629_bb0010","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3390\/microorganisms11082046","article-title":"Genetic diversity of hepatitis B and C viruses revealed by continuous surveillance from 2015 to 2021 in Gabon, Central Africa","volume":"11","author":"Abe","year":"2023","journal-title":"Microorganisms"},{"issue":"Supplement_3","key":"10.1016\/j.ijbiomac.2024.131629_bb0015","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1093\/cid\/ciad336","article-title":"Challenge inoculum for hepatitis C virus controlled human infection model","volume":"77","author":"Liang","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"03","key":"10.1016\/j.ijbiomac.2024.131629_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0043-1771182","article-title":"Molecular epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh","volume":"10","author":"Rahman","year":"2023","journal-title":"Glob. Med. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131629_bb0025","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2023.60","article-title":"Prevalence and genotypes of hepatitis C infection among hemodialysis patients in Bushehr, Iran","volume":"38","author":"Taherkhani","year":"2023","journal-title":"Oman Med. J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131629_bb0030","article-title":"Changing the epidemiology and pattern of hepatitis B and C in the south of Fars Province, southern Iran: 2015-2021","volume":"12","author":"Delam","year":"2023","journal-title":"Jundishapur J. Chron. Dis. Care"},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131629_bb0040","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/AAC.01186-12","article-title":"Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)","volume":"56","author":"McPhee","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131629_bb0045","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3748\/wjg.v29.i6.949","article-title":"Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C","volume":"29","author":"Brzd\u0119k","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131629_bb0050","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2019.01.031","article-title":"Retreatment of patients who failed glecaprevir\/pibrentasvir treatment for hepatitis C virus infection","volume":"70","author":"Wyles","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0055","series-title":"Seminars in Liver Disease","article-title":"Retreatment of hepatitis C virus-infected patients with direct-acting antiviral failures","author":"Pawlotsky","year":"2019"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131629_bb0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","author":"Liver","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131629_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131629_bb0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2015.09.011","article-title":"The importance of resistance to direct antiviral drugs in HCV infection in clinical practice","volume":"64","author":"Sarrazin","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0075","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00705-020-04716-1","article-title":"Global prevalence of HCV and\/or HBV coinfections among people who inject drugs and female sex workers who live with HIV\/AIDS: a systematic review and meta-analysis","volume":"165","author":"Rashti","year":"2020","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0080","series-title":"Guidelines for the Care and Treatment of Persons Diagnosed With Chronic Hepatitis C Virus Infection: Web Annex 3.1: Adult Hepatitis C Virus Treatment Systematic Review","author":"Zoratti","year":"2018"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131629_bb0085","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.cld.2017.06.007","article-title":"Primer on hepatitis C virus resistance to direct-acting antiviral treatment: a practical approach for the treating physician","volume":"21","author":"Weisberg","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/978-1-4939-7000-1_26","article-title":"Protein Data Bank (PDB): the single global macromolecular structure archive","author":"Burley","year":"2017","journal-title":"Protein Crystallogr.: Methods Protoc."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0095","series-title":"Review on Discovery Studio: An Important Tool for Molecular Docking","author":"Pawar","year":"2021"},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0100","series-title":"The PyMOL Molecular Graphics System (DeLano Scientific, San Carlos, CA)","author":"DeLano","year":"2002"},{"issue":"D1","key":"10.1016\/j.ijbiomac.2024.131629_bb0105","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0110","article-title":"Discovery studio modeling environment","author":"Biovia","year":"2017","journal-title":"Release"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.131629_bb0115","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2024.131629_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","article-title":"AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules","volume":"91","author":"Pearlman","year":"1995","journal-title":"Comput. Phys. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131629_bb0125","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1021\/acs.jctc.1c00571","article-title":"Development and benchmarking of open force field v1. 0.0\u2014the parsley small-molecule force field","volume":"17","author":"Qiu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0130","doi-asserted-by":"crossref","DOI":"10.1142\/S1088424623500785","article-title":"Azacalixphyrin nanostructures","author":"Ferry","year":"2023","journal-title":"J. Porphyrins Phthalocyanines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131629_bb0135","article-title":"Antechamber: an accessory software package for molecular mechanical calculations","volume":"222","author":"Wang","year":"2001","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131629_bb0140","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald","volume":"9","author":"Salomon-Ferrer","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128812","article-title":"Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2","volume":"258","author":"Waqas","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131629_bb0150","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131629_bb0155","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.131629_bb0160","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1080\/07391102.2023.2188958","article-title":"Structure-based small inhibitors search combined with molecular dynamics driven energies for human programmed cell death-1 (PD-1) protein","volume":"41","author":"Waqas","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.131629_bb0165","series-title":"The Cambridge World History of Human Disease","author":"Kenneth","year":"1993"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131629_bb0170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/acsomega.1c04764","article-title":"In silico drug designing for ala438 deleted ribosomal protein S1 (RpsA) on the basis of the active compound Zrl 15","volume":"7","author":"Wadood","year":"2021","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131629_bb0175","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1080\/07391102.2019.1662849","article-title":"Molecular modeling, simulation and principal component analysis of binding of resveratrol and its analogues with DNA","volume":"38","author":"Nair","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.131629_bb0180","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.3390\/ijms20246256","article-title":"Structural and dynamic characterizations highlight the deleterious role of SULT1A1 R213H polymorphism in substrate binding","volume":"20","author":"Dash","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"32","key":"10.1016\/j.ijbiomac.2024.131629_bb0185","doi-asserted-by":"crossref","first-page":"22129","DOI":"10.1039\/C6CP03670H","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 6. Capability to predict protein\u2013protein binding free energies and re-rank binding poses generated by protein\u2013protein docking","volume":"18","author":"Chen","year":"2016","journal-title":"Phys. Chem. Chem. Phys."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024024346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024024346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T13:10:05Z","timestamp":1715173805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024024346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":37,"alternative-id":["S0141813024024346"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131629","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the mechanisms of Sofosbuvir resistance in HCV NS3\/4A protease: Structural and molecular simulation-based insights","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131629"}}